The Global Crohn's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.
• Trends in partnering deals
• Top deals by value
• Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of partnering trends.
Chapter 1 provides an overview of the trends in partnering since 2012, including a summary of deals by industry sector, stage of development, deal type, and technology type.
Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.
Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2012. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.
Chapters 5 and 6 provide a summary of M&A deals since 2012 where the acquired company is active in the therapy area of interest.
Chapters 7 and 8 provide a summary of financings since 2012 where the financed company is active in the therapy area of interest.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.
Provides understanding and access to the Chrohn's disease partnering deals and agreements entered into by the worlds leading healthcare companies.Global Crohn's Disease Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:
• In-depth understanding of deal trends since 2012
• Access to headline, upfront, milestone and royalty data
• Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2012
• Insight into key deal terms included in contracts, where disclosed
• Understand the key deal terms companies have agreed in deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Chapter 1 - Therapypartnering trends in numbers
Partnering in numbers √ź by year
Partnering in numbers √ź most active
Partnering in numbers √ź by industry sector
Partnering in numbers √ź by deal type
Partnering in numbers √ź by technology type
Partnering in numbers √ź by stage of development
Chapter 2 - Most active dealmakers
Chapter 3 - Partnering deals directory
Partnering deals directory √ź by company A-Z
Partnering deals directory √ź by deal value
Partnering deals directory √ź by industry sector
Partnering deals directory √ź by deal type
Partnering deals directory √ź by stage of development
Partnering deals directory √ź by technology area
Chapter 4 - Partnering deals with a contract document
About Wildwood Ventures
Recent titles from CurrentPartnering
TABLE OF FIGURES
Figure 1: Partnering frequency by year
Figure 2: Partnering most active
Figure 3: Partnering by industry sector
Figure 4: Partnering by deal type
Figure 5: Partnering by technology area
Figure 6: Partnering by stage of development
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.